Author: Minichart

us corporate news

Dave Inc. Announces $150 Million Convertible Notes Offering with Share Repurchase and Capped Call Transactions to Enhance Shareholder Value 1

Minichart

March 4, 2026

Dave Inc. Announces Proposed Offering of \$150 Million Conve...

Continue Reading 0

us corporate news

Jones Lang LaSalle (JLL) Quarterly and Annual Financial Results 2023-2025: Segment Revenue, EBITDA, and Operating Income Analysis

Minichart

March 4, 2026

Jones Lang LaSalle (JLL) Reports Strong Revenue and EBITDA G...

Continue Reading 0

us corporate news

Fortitude Gold Reports 2025 Financial Results: Production, Earnings, and Expansion Plans in Nevada

Minichart

March 4, 2026

Fortitude Gold Corp (FTCO) Reports 2025 Financial Results an...

Continue Reading 0

us corporate news

Diamond Hill Shareholders Approve Acquisition by First Eagle Investment Management, Closing Expected Q2 2026

Minichart

March 4, 2026

Diamond Hill Shareholder Approval of First Eagle Acquisition...

Continue Reading 0

us corporate news

Vertiv Completes $2.1 Billion Investment Grade Bond Offering and $2.5 Billion Revolving Credit Facility to Bolster Liquidity and Growth Strategy 1

Minichart

March 4, 2026

Vertiv Holdings Co Completes \$2.1 Billion Bond Offering and...

Continue Reading 0

us corporate news

The Eastern Company Reports 2025 Financial Results, Restructuring Actions, and New $100 Million Credit Facility

Minichart

March 4, 2026

The Eastern Company Reports Q4 and Full Year 2025 Results: R...

Continue Reading 0

us corporate news

Hyster-Yale 2025 Financial Results: Tariff Impact, Market Outlook, and Cost Reduction Initiatives for 2026

Minichart

March 4, 2026

Hyster-Yale Reports Q4 and Full-Year 2025 Results: Key Inves...

Continue Reading 0

us corporate news

Iterum Therapeutics plc Files Form 8-K Announcing Strategic Alternatives and Potential Wind-Down Plans – March 2026

Minichart

March 4, 2026

Iterum Therapeutics plc Receives Nasdaq Delisting Notice, Re...

Continue Reading 0

us corporate news

Hyster-Yale, Inc. Financial Performance and Key Metrics 2021-2025: Revenues, Profit, Cash Flow, and Segment Analysis

Minichart

March 4, 2026

Hyster-Yale, Inc. Financial Performance Update – Key Insight...

Continue Reading 0

us corporate news

Delcath Systems’ CHOPIN Phase 2 Trial Shows Improved Survival with Combined Hepatic Perfusion and Immunotherapy in Metastatic Uveal Melanoma (Published in The Lancet Oncology)

Minichart

March 4, 2026

Delcath Systems Announces Landmark CHOPIN Trial Results in T...

Continue Reading 0